| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/19/2000 | EP1019435A1 Amplification of response from expressed recombinant protein |
| 07/19/2000 | EP1019434A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 07/19/2000 | EP1019432A1 The ob receptor and methods of diagnosing and treating weight |
| 07/19/2000 | EP1019431A1 Novel rnase p |
| 07/19/2000 | EP1019429A1 Antisense and antigene therapeutics with improved binding properties and methods for their use |
| 07/19/2000 | EP1019428A2 Inverted chimeric and hybrid oligonucleotides |
| 07/19/2000 | EP1019402A1 Polymorphic forms of a growth hormone secretagogue |
| 07/19/2000 | EP1019370A1 Ace-inhibitor nitric salts |
| 07/19/2000 | EP1019369A1 Thio derivatives as naaladase inhibitors |
| 07/19/2000 | EP1019364A2 Inhibitors of protein tyrosine phosphatase |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019096A2 Bioresorbable compositions for implantable prostheses |
| 07/19/2000 | EP1019092A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 07/19/2000 | EP1019091A1 50 human secreted proteins |
| 07/19/2000 | EP1019089A2 Long-acting drugs and pharmaceutical compositions comprising them |
| 07/19/2000 | EP1019087A1 Ganglioside immunostimulating complexes and uses thereof |
| 07/19/2000 | EP1019084A1 Novel antimicrobial polypeptide and methods of use |
| 07/19/2000 | EP1019083A1 Methods and compositions for the selective modification of nucleic acids |
| 07/19/2000 | EP1019082A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/19/2000 | EP1019081A2 Apolipoprotein e/growth factor complexes and methods of use |
| 07/19/2000 | EP1019080A2 Modulation of lerk-2-mediated cell adhesion |
| 07/19/2000 | EP1019079A1 Modulation of nitric oxide production |
| 07/19/2000 | EP1019078A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis |
| 07/19/2000 | EP1019077A1 Novel exendin agonist compounds |
| 07/19/2000 | EP1019076A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019073A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP1019072A1 Method for assisting in differential diagnosis and treatment of autistic syndromes |
| 07/19/2000 | EP1019071A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods |
| 07/19/2000 | EP1019070A1 Bradykinin analogs as selective inhibitors of cell activation |
| 07/19/2000 | EP1019069A2 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease |
| 07/19/2000 | EP1019068A1 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 07/19/2000 | EP1019065A1 Multiple target hybridizing nucleic acids, their preparation, compositions, formulation, kits and applications |
| 07/19/2000 | EP1019061A1 Urease-responsive delivery systems for diagnostic and therapeutic applications |
| 07/19/2000 | EP1019046A1 Protease inhibitors |
| 07/19/2000 | EP1019043A1 Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same |
| 07/19/2000 | EP1019034A2 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/19/2000 | EP1019031A1 Biodegradable macromers for the controlled release of biologically active substances |
| 07/19/2000 | EP1019028A1 $i(CHLAMYDIA) PROTEIN, GENE SEQUENCE AND USES THEREOF |
| 07/19/2000 | EP1019027A1 Implantable collagen-containing putty material |
| 07/19/2000 | EP1019026A2 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
| 07/19/2000 | EP1019025A1 Peptide/lipid complex formation by co-lyophilization |
| 07/19/2000 | EP1019019A1 Buccal, polar and non-polar spray or capsule |
| 07/19/2000 | EP1019016A1 Active synergetic complex and cosmetic and/or pharmaceutical product containing this complex |
| 07/19/2000 | EP1019010A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 07/19/2000 | EP1018896A1 Nutritional composition for the treatment of pressure ulcers |
| 07/19/2000 | EP1018879A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 07/19/2000 | EP1018875A1 Insecticidal peptides from segestria sp. spider venom |
| 07/19/2000 | EP1018863A1 Toxin genes from the bacteria xenorhabdus nematophilus and photorhabdus luminescens |
| 07/19/2000 | EP0863766B1 Methods for treating injury or degeneration of photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/19/2000 | EP0821551A4 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 07/19/2000 | EP0777495B1 Stable, aqueous alfa interferon solution formulations |
| 07/19/2000 | EP0722320B1 Use of nitric oxide-releasing compounds as medicaments for hypoxic cell radiation sensitization |
| 07/19/2000 | EP0679091B1 Chemotactic factors for human spermatozoa and their use in human assisted fertilization |
| 07/19/2000 | EP0527815B1 Hepatitis c virus epitopes |
| 07/19/2000 | EP0389570B2 High integrity liposomes and method of preration and use |
| 07/19/2000 | CN1260835A Truncated vegf-related proteins |
| 07/19/2000 | CN1260833A LAG-3 splice variants |
| 07/19/2000 | CN1260780A Ace-inhibitor nitric salts |
| 07/19/2000 | CN1260725A Conjugate composing folic acid antagonist and carrier |
| 07/19/2000 | CN1260722A Nerve growth factor as vaccine adjuvant |
| 07/19/2000 | CN1260721A Use of cartilage oligeomeric matrix protein for treatment of rheumatoid |
| 07/19/2000 | CN1260720A Compositions useful as fibrin sealants |
| 07/19/2000 | CN1260715A Treatment of diabetes with rosiglitazone and insulin |
| 07/19/2000 | CN1260714A Controlled release pharmaceutical preparation with ACE inhibitor as active agent |
| 07/19/2000 | CN1260398A Expression system for producing recombined human erythrogenin, method for purifying secreted human erythrogenin and its use |
| 07/19/2000 | CN1054609C Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor |
| 07/19/2000 | CN1054599C Hydroxamic acid derivatives and preparation method and use |
| 07/19/2000 | CN1054598C Pharmacalogically active hydrazine derivatives and process for preparation thereof |
| 07/19/2000 | CN1054543C Composition for sustained and controlled release of medicamentous substances and process for preparing same |
| 07/19/2000 | CN1054509C Synergistic interplay of lymphokines and dsRNAs |
| 07/18/2000 | US6090958 N-(8-carboxyoctyl)-o-hydroxybenzamide and salts |
| 07/18/2000 | US6090947 Method for the synthesis of pyrrole and imidazole carboxamides on a solid support |
| 07/18/2000 | US6090924 Human-Human CLNH5-specific antibodies |
| 07/18/2000 | US6090923 Immunoglobulin that preferentially binds a human cytotoxin; for the treatment of virus infected or tumor target cells |
| 07/18/2000 | US6090922 Imunoglobulin that binds mammalian adhesive protein |
| 07/18/2000 | US6090918 Polypeptide associated with the inhibition of prostaglandin biosynthesis and treating inflammation |
| 07/18/2000 | US6090916 Protein with anticlotting activity; for treatment and prevention of thrombotic disorders |
| 07/18/2000 | US6090914 CTLA4/CD28Ig hybrid fusion proteins and uses thereof |
| 07/18/2000 | US6090796 Anticancer, antitumor agent; viricide |
| 07/18/2000 | US6090795 Human derived monocyte attracting purified peptide products useful in a method of treating infection and neoplasms in a human body |
| 07/18/2000 | US6090789 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof |
| 07/18/2000 | US6090787 Antithrombotic agents |
| 07/18/2000 | US6090785 Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative agents |
| 07/18/2000 | US6090784 RNA polymerase II peptides and methods of use |
| 07/18/2000 | US6090783 A protein which binds to a transcriptional repressive region in u5 region of human t-cell leukemia virus tupe 1 gene ltr, comprises a domain common to kruppel type transcriptional repressive factors and five kruppel type zinc finger doamin |
| 07/18/2000 | US6090782 Contacting hematopoietic cells with a stem cell proliferation inhibition amount of a peptide or polypeptide having specific amino acid sequence |
| 07/18/2000 | US6090781 Formulation comprising nerve growth factor and acetate buffer from ph 5 to 6 containing sodium acetate, sodium chloride and benzyl alcohol provide enhanced stability of nerve growth factor for use in promoting, repair, survival, differentiation |
| 07/18/2000 | US6090780 Histidyl-proline diketopiperazine and method of use |
| 07/18/2000 | US6090779 Use of hemoglobin to treat septic shock |
| 07/18/2000 | US6090778 Neurturin and related growth factors |
| 07/18/2000 | US6090777 Administering exogenous c1-esterase inhibitor, alone or with other drugs to a patient with acute myocardial infarction or at risk for acute myocardial infarction |
| 07/18/2000 | US6090775 Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 07/18/2000 | US6090626 Antisense oligonucleotide modulation of raf gene expression |
| 07/18/2000 | US6090621 Monoclonal antibody that binds specifically to hydrolyase enzyme; for treatment of calcium signaling, phosphatidylinositol and inositol polyphosphate defects; gene therapy; antiproliferative agents |
| 07/18/2000 | US6090618 DNA constructs and viral vectors comprising a smooth muscle promoter |
| 07/18/2000 | US6090612 Polynucleotide sequence coding a phosphatase enzymes; a diagnostic tool for monitoring enzyme activity in sample; for treatment of nervous system disorders, cardiovascular disorders and tumors; antitumor agents |
| 07/18/2000 | US6090611 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 07/18/2000 | US6090609 Crystallized N-terminal domain of influenza virus matrix protein M1 and method of determining and using same |
| 07/18/2000 | US6090608 Viral expression vector coding heterologous proteins; for the treatment of thalassemia, hemopoietic defects, bacterial and viral infctions, atherosclerosis, autoimmune diseases or allergies; anticarcinogenic agents |